Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT (2019)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fimmu.2019.01157
- Subjects: HEMOGLOBINAS; HEMATOLOGIA; ANEMIA
- Keywords: Paroxysmal nocturnal hemoglobinuria; Intravascular hemolysis; Extravascular hemolysis; Complement inhibition; Eculizumab; Ravulizumab; Compstatin
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 10, art. 1157, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
RISITANO, Antonio M. et al. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Frontiers in Immunology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.01157. Acesso em: 20 maio 2024. -
APA
Risitano, A. M., Marotta, S., Ricci, P., Marano, L., Frieri, C., Cacace, F., et al. (2019). Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Frontiers in Immunology, 10. doi:10.3389/fimmu.2019.01157 -
NLM
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj AG, Calado RT, Scheinberg P, Notaro R, Latour RP de. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT [Internet]. Frontiers in Immunology. 2019 ; 10[citado 2024 maio 20 ] Available from: https://doi.org/10.3389/fimmu.2019.01157 -
Vancouver
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj AG, Calado RT, Scheinberg P, Notaro R, Latour RP de. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT [Internet]. Frontiers in Immunology. 2019 ; 10[citado 2024 maio 20 ] Available from: https://doi.org/10.3389/fimmu.2019.01157 - Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH)
- Telomere dynamics in mice and humans
- A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome
- Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia
- Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia. [Carta]
- Latin American Collaborative Research on Aplastic Anemia (LARAA): creating a regional registry
- Avaliação da qualidade dos concentrados de hemácias com lipemia durante o armazenamento
- Spectrum of clonal hematopoiesis in VEXAS syndrome
- Shwachman-Diamond syndrome: first molecular diagnosis in a Brazilian child
- Variações da qPCR e seus usos
Informações sobre o DOI: 10.3389/fimmu.2019.01157 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
